ReviewCurrent gastroenterology reports2004
Management of extraintestinal manifestations and other complications of inflammatory bowel disease.
Review in Current gastroenterology reports, 2004. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
21 citing papers in PubMed, 65 citations in OpenAlex.
- Concurrent Ulcerative Colitis in a Pregnant Patient with Rheumatoid Arthritis.Internal medicine (Tokyo, Japan) · 2024Article
- Anti-Inflammatory and Antioxidant Activities of the Methanolic Extract ofMediators of inflammation · 2020Article
- A Unique Triad: Ulcerative Colitis, Primary Sclerosing Cholangitis, and Autoimmune Hemolytic Anemia.Cureus · 2018Article
- Ophthalmic manifestations in patients with inflammatory bowel disease: A review.World journal of gastroenterology · 2017Review
- Article
- Flavonoids in Inflammatory Bowel Disease: A Review.Nutrients · 2016Review
- The Prevalence of Headache in Crohn's Disease: Single-Center Experience.Gastroenterology research and practice · 2016Article
- Interval colorectal carcinoma: An unsolved debate.World journal of gastroenterology · 2015Review
- Intestinal epithelium-specific knockout of the cytochrome P450 reductase gene exacerbates dextran sulfate sodium-induced colitis.The Journal of pharmacology and experimental therapeutics · 2015Article
- Inflammatory bowel disease cause-specific mortality: a primer for clinicians.Inflammatory bowel diseases · 2014Review
- Clinical characteristics and treatment of inflammatory bowel disease: a comparison of Eastern and Western perspectives.World journal of gastroenterology · 2014Article
- A Case of Human Leukocyte Antigen (HLA) B27-Positive Intestinal Behçet's Disease with Crohn's Disease-Like Anal Fistulas.Clinical medicine insights. Case reports · 2014Article
- Diagnosis and therapeutic management of extra-intestinal manifestations of inflammatory bowel disease.Drugs · 2012Review
- Ulcerative colitis: a challenge to surgeons.International journal of preventive medicine · 2012Article
- The role of portal vein thrombosis in the clinical course of inflammatory bowel diseases: report on three cases and review of the literature.Gastroenterology research and practice · 2012Article
- Current management of inflammatory bowel disease and colorectal cancer.Gastrointestinal cancer research : GCR · 2011Article
- Arthritis associated with ulcerative colitis: our experience in palermo.The Libyan journal of medicine · 2009Article
- Extraintestinal manifestations of inflammatory bowel disease.Current gastroenterology reports · 2008Review
- Extraintestinal manifestations of inflammatory bowel disease: focus on the musculoskeletal, dermatologic, and ocular manifestations.MedGenMed : Medscape general medicine · 2007Review
- Development of ulcerative colitis during the course of rheumatoid arthritis: Association with selective IgA deficiency.World journal of gastroenterology · 2006Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The past 18 months have seen many studies of the prevalence, pathogenesis, and treatment of the extraintestinal manifestations of inflammatory bowel disease (IBD). Inhibitors of tumor necrosis factor alpha have shown effectiveness in randomized trials for the treatment of spondyloarthropathies and ocular manifestations. Open-label studies suggest that these agents may be effective for pyoderma gangrenosum as well. The epidemiology of primary sclerosing cholangitis (PSC), and its relationship to IBD, is becoming clearer. Colorectal neoplasia in PSC remains an important clinical problem. Osteoporosis occurs more commonly in IBD, but the relative importance of corticosteroid use versus underlying chronic bowel inflammation as risk factors remains controversial. Chromoendoscopy may be an important means to improve detection of colorectal neoplasia in IBD. Observational studies suggest that prolonged use of aminosalicylates is associated with decreased risk of neoplasia, but data are conflicting. A randomized trial of ursodeoxycholic acid in PSC showed decreased risk of colorectal neoplasia in patients receiving the drug relative to those on placebo.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.